News

Both DelSite Biotechnologies and ElSohly Laboratories have cooperative R&D agreements with the National Cancer Institute (NCI). Whereas DelSite’s agreement covers the development of a nasal powder vaccine for

In the study published in the March issue of the Journal of Infectious Disease, guinea pigs immunized with the CMV alphavaccine before becoming pregnant and infected with CMV

The drug, which is currently approved to treat lung and colorectal cancers, may also help stop the growth of tumors called gliomas temporarily when combined with the standard

The placebo-controlled trial demonstrated that Alitretinoin was effective in patients suffering from severe and refractory chronic hand dermatitis, as determined by the stringent endpoint of clear and almost

Regular usage of tea tree oil, which is sometimes used undiluted to help get rid of spots, acne and insect bites, could increase the user's risk of contracting

The study of 500 head and neck patients, conducted in Denmark, was designed to test whether Aranesp would increase the efficacy of radiation therapy for cancer patients by

The company said that it had received a letter from shareholder David Katz, president of Matrix Asset Advisors, commenting on the company's quarterly results and suggesting that MedImmune

The company and MassDevelopment have also finalized agreements related to the facility’s utility infrastructure, including waste water treatment and use of electricity, water and natural gas. The facility

Priority review status is assigned to drug products that, if approved, would offer a significant improvement compared to marketed products in the treatment, diagnosis or prevention of a